News
-
-
COMMUNIQUÉ DE PRESSE
Swiss Life continues to grow, increases profit from operations and raises dividend – “Swiss Life 2027” well on track
Swiss Life Holding AG reports stable net profit of CHF 1.26 billion and increased profit from operations. Dividend raised. 'Swiss Life 2027' program progresses well -
COMMUNIQUÉ DE PRESSE
Swiss Life poursuit sa croissance, accroît son bénéfice d’exploitation et augmente le dividende – « Swiss Life 2027 » en bonne voie
Swiss Life annonce une croissance du bénéfice d'exploitation, une augmentation du dividende et l'avancement du programme Swiss Life 2027. Les chiffres clés incluent des bénéfices stables, des primes et des actifs en hausse -
COMMUNIQUÉ DE PRESSE
Siltronic AG: Robust business performance in 2025 demonstrates resilience despite challenging conditions
Siltronic AG reports robust business performance in 2025 amid challenging conditions. Sales at EUR 1,346.7 million with EBITDA margin of 23.5% compared to EUR 363.8 million in 2024 -
-
-
COMMUNIQUÉ DE PRESSE
BioVersys Announces First Patient Dosed in Phase 2b Clinical Trial of AlpE in Pulmonary Tuberculosis
BioVersys announces the first patient dosed in a Phase 2b clinical trial of AlpE for pulmonary tuberculosis, collaborating with GSK under UNITE4TB project. Results expected by end of 2027 -
-
-